Cineplex Stock May Be a Brilliant Bet Going Into Summer

Cineplex (TSX:CGX) stock may be on the cusp of a summertime boom. But with resurgence risks still in full swing, should you be a buyer?

| More on:

Cineplex (TSX:CGX) stock has been under pressure again, with the name recently dipping just over 20% from its six-month high. With the ongoing third wave of COVID-19, the Canadian movie theatre giant is due for another round of brutal numbers.

On the other side of this horrific spring surge is a summer season that could have the potential to be far brighter than last year’s. Every day that goes by, more Canadians are getting vaccinated, bringing us ever so closer to herd immunity. As the insidious coronavirus looks to abate going into the summer season, the nation will have a chance to accelerate its vaccination efforts and gain the upper hand over new variants.

Be optimistic while others are pessimistic

It’s been a dark spring, with COVID-19 restrictions still in place for many provinces. Despite this, people are as optimistic as ever amid the ongoing vaccine rollout. Summer is just around the corner, and normalcy is within grasp. While COVID-19 probably won’t be eradicated this year or even next year, I think that fully vaccinated Canadians who’ve received both doses will feel far more confident about heading back to establishments like movie theatres, arcades, and all the sort once the government removes restrictions.

Such an environment could fuel an epic boom for Cineplex. The company may finally get a chance to recover after nearly a year and a half of depressed revenues at the hands of restrictions. For those willing to put up with the volatility and give Cineplex a free pass for its meagre first-quarter results, I think there’s a lot to gain, as we make major strides to the light at the end of the tunnel.

Cineplex: The road ahead looks bright

The company is fresh off an 85% year-over-year plunge in quarterly earnings. Net losses were also clocked in at just shy of $90 million. It was a brutal quarter, but should it have been a surprise? Probably not.

Fellow Fool contributor Chris MacDonald seems to think Cineplex is still a top reopening play after its latest post-earnings pullback, and I think he’s right on the money. MacDonald highlights that high-risk establishments like theatres are poised to revamp their air-intake systems to make consumers feel safer and more comfortable:

“Movie theatre operators have been reiterating that their operations are much safer when compared to retail stores and restaurants. They believe that since the theatres are spacious, social distancing won’t be a problem,” MacDonald wrote. “Furthermore, businesses are looking to alter their air-intake system to substantially increase airflow. Such upgrades could go a long way to providing a road map for regulators to open up movie theatres.”

I think such initiatives will be vital to Cineplex’s recovery. Even people who’ve been vaccinated with both doses and the latest booster will still get anxious if they hear someone coughing down the aisle.

Foolish takeaway on Cineplex stock

With a growing backlog of theatrical releases, pent-up demand for social activities, and restrictions likely to be lifted, I think Cineplex stock is a must-own for venturesome Canadian investors who are no strangers to extreme volatility.

An autumn resurgence could stop Cineplex’s recovery in its tracks. That’s the biggest risk investors need to come to terms with. Regardless, I’m still a fan of the risk/reward scenario going into the summer and would look to scoop up shares after its post-earnings flop.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC.

More on Dividend Stocks

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »

concept of real estate evaluation
Dividend Stocks

How to Earn a TFSA Paycheque Every Month and Pay No Taxes on It

Canadian REITs can turn your TFSA into a monthly paycheque machine for life. Here's how Morguard North American Residential REIT…

Read more »

A plant grows from coins.
Dividend Stocks

The Smartest Dividend-Growth Stocks to Buy With $1,000 Right Now

New dividend-growth investors should consider CN Rail (TSX:CNR) stock and another top play if they're looking to build wealth over…

Read more »

Dividend Stocks

The 3 Top Canadian Stocks to Buy With $1,000 Right Now

If you want consistent income, look to consistent dividend payers. These three stocks are some of the best in the…

Read more »

A worker gives a business presentation.
Dividend Stocks

Want a 6% Average Yield? 3 TSX Stocks to Buy Today

These stocks pay good dividends that should continue to grow.

Read more »

chart reflected in eyeglass lenses
Dividend Stocks

Is Alimentation Couche-Tard Stock a Buy for its 0.9% Dividend Yield?

Couche-Tard stock's small yield is not enticing, but its growth potential could be a wealth creator.

Read more »

Hourglass and stock price chart
Dividend Stocks

5.2% Dividend Yield! I’m Buying This TSX Stock and Holding for Decades!

With its 5.2% dividend yield, Toronto-Dominion Bank (TSX:TD) is a stock I'm eagerly buying.

Read more »